Place du Rituximab dans le traitement de la sclérose en plaques

dc.contributor.advisorN. KISSANI
dc.contributor.authorImane HAKIM
dc.date.accessioned2023-09-19T14:15:24Z
dc.date.accessioned2026-01-28T12:21:13Z
dc.date.available2023-09-19T14:15:24Z
dc.date.issued2022
dc.description.collaboratorM. CHRAA
dc.description.collaboratorN. LOUHAB
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/22033
dc.identifier.urihttps://doi.org/10.83129/toubkal-1547
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Marrakechfr_FR
dc.publisherSciences médicalesfr_FR
dc.subject.otherNeurologie, Physiologie, Neurologie
dc.subject.specificSclérose en plaques
dc.subject.specificRituximab
dc.subject.specificSévérité
dc.titlePlace du Rituximab dans le traitement de la sclérose en plaquesfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
these33-22.pdf
Size:
3.29 MB
Format:
Adobe Portable Document Format